Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-26-001024·Avidity Biosciences, Inc.
Schedule 13G ownership disclosure
Avidity Biosciences Inc
Common Stock, par value $0.0001 per share · CUSIP: 05370A108
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avoro Capital Advisors LLC
Shares: 8,515,792.00 · Class: 5.54%
- Behzad Aghazadeh
Shares: 8,515,792.00 · Class: 5.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-26-001024
- Form type
- SCHEDULE 13G/A
- Filer
- Avidity Biosciences, Inc.
- CIK
- CIK 1599901
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership